Noradrenaline as an alternative medical treatment to terlipressin in the management of hepatorenal syndrome type 1

Gastroenterol Hepatol. 2018 Aug-Sep;41(7):440-441. doi: 10.1016/j.gastrohep.2017.08.007. Epub 2017 Oct 18.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenergic Agonists / therapeutic use*
  • Albumins / therapeutic use
  • Diarrhea / chemically induced
  • Drug Substitution
  • Female
  • Hepatorenal Syndrome / drug therapy*
  • Hepatorenal Syndrome / etiology
  • Hepatorenal Syndrome / surgery
  • Hernia, Umbilical / surgery
  • Herniorrhaphy
  • Humans
  • Liver Cirrhosis, Alcoholic / complications
  • Liver Transplantation
  • Middle Aged
  • Midodrine / therapeutic use
  • Norepinephrine / therapeutic use*
  • Octreotide / therapeutic use
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Splanchnic Circulation / drug effects*
  • Terlipressin / adverse effects
  • Terlipressin / therapeutic use*
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Adrenergic Agonists
  • Albumins
  • Vasoconstrictor Agents
  • Midodrine
  • Terlipressin
  • Octreotide
  • Norepinephrine